Sachdev Amit 4

What Happened

• Amit Sachdev, EVP, Chief Patient & External Affairs Officer at Vertex, exercised two option grants on 2026-02-19 to acquire 48,505 shares (23,479 at $155.57 = $3,652,628; 25,026 at $187.53 = $4,693,126; total cost ≈ $8,345,754).
• The filing also reports multiple open‑market sales the same day totaling 58,613 shares sold for aggregate proceeds of $27,479,582 (individual sale prices ranged roughly $463.44–$472.03; weighted averages noted per line).
• Two derivative lines show the option instruments were converted/terminated (reported as disposed at $0) in connection with the exercises. This pattern—exercise followed by same‑day sales—is effectively a cashless exercise and sale of the acquired shares.

Key Details

• Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (within the standard reporting window).
• Exercises: 23,479 @ $155.57 ($3,652,628) and 25,026 @ $187.53 ($4,693,126).
• Open‑market sales: 58,613 shares at prices from ~$463.44 to $472.03; total proceeds ≈ $27,479,582. One line’s weighted average noted as $471.43 (range $471.10–$472.03).
• Shares owned after transaction: not specified in the filing.
• Footnotes: trades were made under a company‑approved Rule 10b5‑1 plan entered 11/18/2025 (F1); options were fully vested (F11). The filer commits to providing a per‑price breakdown on request (F3).

Context

• Because the exercises and sales occurred the same day and the derivative lines report $0 disposals, this is effectively a cashless exercise (exercise of options followed by sale of shares). Such activity is commonly driven by option exercise/tax-liability management rather than an expressed change in view on the company.
• Trades were executed under a pre‑arranged 10b5‑1 trading plan, which typically means the sales were scheduled in advance. This is routine insider selling and not, by itself, evidence of new information about company fundamentals.